[No Title Available]

Lacaz, C. S.; Porto, Erly Carlos; Martins, J.E.C.; Heins‐Vaccari, Elisabeth Maria; Melo, Natalina Takahashi de

doi:10.1590/s0036-46652002000500013

Cited by 111 publications

(170 citation statements)

References 0 publications

Supporting

Mentioning

138

Contrasting

Unclassified

Order By: Relevance

“…This patient did not present any pulmonary manifestations which are considered, together with the neurological ones, as the two principal forms of the disease 2,13,20,23 .…”

Section: Discussionmentioning

confidence: 67%

“…Cryptococcus neoformans was isolated for the first time by Sanfelice in this same year, from spoiled fruit juice 2,19,20 . In Brazil, the first publication was made by Almeida & Lacaz, in 1941 20 .…”

Section: Discussionmentioning

confidence: 99%

“…It is found in the ground and in tissues, secretions and excrements of animals and of the human beings. It is not contagious among humans 2,19,20 . Its transmission to humans occurs, mainly, by inhalation of nonencapsulated yeast forms or of those with thin capsules, transmitted, particularly, from contact with excrement of pigeons 12,26 .…”

Section: Discussionmentioning

confidence: 99%

“…In its generalized forms, especially in patients who have AIDS, it presents acneiform injuries, papules, nodules, vesicles, ulcers, ecchymosis and rarely cellulitis 12,20,21,33 . It can appear similar to some dermatological diseases, among which are the following: basal cell carcinoma, disseminated giant molluscum contagiosum, paracoccidioidomycosis and histoplasmosis 11,20,21 . The patient in this study presented innumerable injuries mimicking molluscum contagiosum, characterizing a rare exuberant clinical manifestation.…”

Section: Discussionmentioning

confidence: 99%

“…Cryptococcosis, also known as torulosis, Busse -Buschke's disease and European blastomycosis is a cosmopolitan illness, with opportunist behavior 2,11,12,14,20,24,29 .…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Disseminated cutaneous cryptococcosis in a patient with AIDS

Dinato

Dinato²,

Nakanishi³

et al. 2006

Rev. Inst. Med. trop. S. Paulo

View full text Add to dashboard Cite

SUMMARYThe authors study a patient carrying Aids, with exuberant dermatological manifestations of cryptococcosis. They stress the therapeutic effectiveness of short-term amphotericin B. The authors reviewed cases of cutaneous infection with Cryptococcus reported in the national and international literature, verifying that the frequency has increased with the AIDS epidemic. Also, they discuss about the differential diagnosis with some cases of dermatosis, particularly with the disseminated giant molluscum contagiosum. In relation to the therapy, they affirm that the choice of drug depends on the organ involved, as well as the immune state of the patient.

show abstract

“…This patient did not present any pulmonary manifestations which are considered, together with the neurological ones, as the two principal forms of the disease 2,13,20,23 .…”

Section: Discussionmentioning

confidence: 67%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

“…Cryptococcosis, also known as torulosis, Busse -Buschke's disease and European blastomycosis is a cosmopolitan illness, with opportunist behavior 2,11,12,14,20,24,29 .…”

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Disseminated cutaneous cryptococcosis in a patient with AIDS

Dinato

Dinato²,

Nakanishi³

et al. 2006

Rev. Inst. Med. trop. S. Paulo

View full text Add to dashboard Cite

show abstract

Medicinal Plants and Pharmaceutical Technology

Silva

Couto

Bresolin

2012

Plant Bioactives and Drug Discovery

View full text Add to dashboard Cite

Fundamentals of paracoccidioidomycosis treatment

Fróes

Caligiorne

2011

Drug Development Research

View full text Add to dashboard Cite

Paracoccidioidomycosis (PCM) is the most important mycosis in Latin America. The etiological agent is the fungus, Paracoccidioides brasiliensis. Approximately 1 million people are infected with the fungus, 10% of whom will show symptoms of the disease. However, clinical and laboratorial studies addressing the diagnosis for this disease are both scarce and diverse in terms of definition. Nevertheless, two main advances were included in the portfolio of available diagnostic methods for paracoccidioidomycosis during the last decades: the detection of antibodies against P. brasiliensis antigens by serological methods, and the detection of the fungi DNA in peripheral blood and fragments of lesions using the polymerase chain reaction (PCR) assay and species-specific primers. Normally, the treatment of PCM is quite prolonged because of the immunosuppressed profile of the patients and the ability of P. brasiliensis to survive in the tissues even after long-term treatment. Case reports indicate that azoles and sulfa compounds can produce positive results in less severe cases of PCM. However, for acute cases of the disease in immunocompromised patients or in cases of neuroparacoccidioidomycosis, there is no standard treatment. Thus, there is a need to establish a standard treatment protocol within the context of the patient clinical profile. Moreover, drug availability to public institutions is an important issue, since new drugs, e.g., second-generation azoles, the echinocandines and immunomodulatory drugs, are not yet available in public hospitals and clinics. Drug Dev Res 72:528-537, 2011.

show abstract

[No Title Available]

Cited by 111 publications

References 0 publications

Disseminated cutaneous cryptococcosis in a patient with AIDS

Disseminated cutaneous cryptococcosis in a patient with AIDS

Medicinal Plants and Pharmaceutical Technology

Fundamentals of paracoccidioidomycosis treatment

Contact Info

Product

Resources

About